Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Neurological Involvement in Childhood Evans Syndrome.

Pincez T, Neven B, Le Pointe HD, Varlet P, Fernandes H, Gareton A, Leverger G, Leblanc T, Chambost H, Michel G, Pasquet M, Millot F, Hermine O, Mathian A, Hully M, Zephir H, Hamidou M, Durand JM, Perel Y, Landman-Parker J, Rieux-Laucat F, Aladjidi N.

J Clin Immunol. 2019 Jan 22. doi: 10.1007/s10875-019-0594-3. [Epub ahead of print]

PMID:
30671780
2.

Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS'CEREVANCE.

Penel Page M, Bertrand Y, Fernandes H, Kherfellah D, Leverger G, Leblanc T, Libbrecht C, Michel G, Jeziorski E, Armari-Alla C, Nelken B, Pellier I, Pasquet M, Perel Y, Aladjidi N.

Am J Hematol. 2018 May 14. doi: 10.1002/ajh.25137. [Epub ahead of print] No abstract available.

PMID:
29756344
3.

Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.

Le Rouzic MA, Fouquet C, Leblanc T, Touati M, Fouyssac F, Vermylen C, Jäkel N, Guichard JF, Maloum K, Toutain F, Lutz P, Perel Y, Manceau H, Kannengiesser C, Vannier JP.

Blood Cells Mol Dis. 2017 Jul;66:11-18. doi: 10.1016/j.bcmd.2017.07.003. Epub 2017 Jul 26.

PMID:
28772256
4.

Reliable assessment of the incidence of childhood autoimmune hemolytic anemia.

Aladjidi N, Jutand MA, Beaubois C, Fernandes H, Jeanpetit J, Coureau G, Gilleron V, Kostrzewa A, Lauroua P, Jeanne M, Thiébaut R, Leblanc T, Leverger G, Perel Y.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26683. Epub 2017 Jul 27.

PMID:
28748541
5.

[Transfusion and its specific problems in pediatrics and neonatology].

Pérel Y, Runel C, Huguenin Y, Renesme L, Aladjidi N.

Transfus Clin Biol. 2017 Sep;24(3):101-105. doi: 10.1016/j.tracli.2017.05.017. Epub 2017 Jul 11. Review. French.

PMID:
28709844
6.

Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.

Ducassou S, Leverger G, Fernandes H, Chambost H, Bertrand Y, Armari-Alla C, Nelken B, Monpoux F, Guitton C, Leblanc T, Fisher A, Lejars O, Jeziorski E, Fouissac F, Lutz P, Pasquet M, Pellier I, Piguet C, Vic P, Bayart S, Marie-Cardine A, Michel M, Perel Y, Aladjidi N.

Br J Haematol. 2017 Jun;177(5):751-758. doi: 10.1111/bjh.14627. Epub 2017 Apr 26.

PMID:
28444729
7.

Impact of shared care program in follow-up of childhood cancer survivors: An intervention study.

Ducassou S, Chipi M, Pouyade A, Afonso M, Demeaux JL, Ducos G, Pérel Y, Ansoborlo S.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26541. Epub 2017 Apr 1.

PMID:
28371178
8.

Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes.

Grimaldi-Bensouda L, Nordon C, Leblanc T, Abenhaim L, Allali S, Armari-Alla C, Berger C, Courcoux MF, Fouyssac F, Guillaumat C, Guitton C, Le Moine P, Mazingue F, Pondarré C, Thomas C, Pasquet M, Perel Y, Leverger G, Aladjidi N.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26389. Epub 2016 Dec 1.

PMID:
27905681
9.

Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.

Sirvent A, Auquier P, Oudin C, Bertrand Y, Bohrer S, Chastagner P, Poirée M, Kanold J, Thouvenin S, Perel Y, Plantaz D, Tabone MD, Yakouben K, Gandemer V, Lutz P, Sirvent N, Vercasson C, Berbis J, Chambost H, Leverger G, Baruchel A, Michel G.

Bone Marrow Transplant. 2017 Jan;52(1):80-87. doi: 10.1038/bmt.2016.205. Epub 2016 Sep 5.

PMID:
27595286
10.

[Multidisciplinarity, education, and training in pediatric oncology-hematology].

Vassal G, Landman-Parker J, Baruchel A, Bergeron C, Rubie H, Coze C, Chastagner P, Leverger G, Bertrand Y, Valteau-Couanet D, Michon J, Couanet D, Rivière AM, Avenell D, Pérel Y, Doz F.

Arch Pediatr. 2015 Dec;22(12):1217-22. doi: 10.1016/j.arcped.2015.09.012. Epub 2015 Nov 18. Review. French.

PMID:
26604021
11.

Paediatric brain tumours: A review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy.

Laprie A, Hu Y, Alapetite C, Carrie C, Habrand JL, Bolle S, Bondiau PY, Ducassou A, Huchet A, Bertozzi AI, Perel Y, Moyal É, Balosso J; radiotherapy committee of SFCE and France Hadron.

Cancer Radiother. 2015 Dec;19(8):775-89. doi: 10.1016/j.canrad.2015.05.028. Epub 2015 Nov 6. Review.

PMID:
26548600
12.

Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort.

Aladjidi N, Fernandes H, Leblanc T, Vareliette A, Rieux-Laucat F, Bertrand Y, Chambost H, Pasquet M, Mazingue F, Guitton C, Pellier I, Roqueplan-Bellmann F, Armari-Alla C, Thomas C, Marie-Cardine A, Lejars O, Fouyssac F, Bayart S, Lutz P, Piguet C, Jeziorski E, Rohrlich P, Lemoine P, Bodet D, Paillard C, Couillault G, Millot F, Fischer A, Pérel Y, Leverger G.

Front Pediatr. 2015 Sep 29;3:79. doi: 10.3389/fped.2015.00079. eCollection 2015.

13.

Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?

Van-Gils J, Harambat J, Jubert C, Vidaud D, Llanas B, Perel Y, Lacombe D, Goizet C.

Eur J Med Genet. 2014 Nov-Dec;57(11-12):639-42. doi: 10.1016/j.ejmg.2014.09.001. Epub 2014 Sep 16.

PMID:
25234363
14.

Paediatric anaplastic large cell lymphoma with leukaemic presentation in children: a report of nine French cases.

Spiegel A, Paillard C, Ducassou S, Perel Y, Plantaz D, Strullu M, Eischen A, Lutz P, Lamant L, Le Deley MC, Brugières L.

Br J Haematol. 2014 May;165(4):545-51. doi: 10.1111/bjh.12777. Epub 2014 Feb 14.

PMID:
24666317
15.

Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Paillard C, Rochette E, Lutz P, Bertrand Y, Michel G, Bordigoni P, Dalle JH, Rohrlich P, Vannier JP, Perel Y, Plantaz D, Leverger G, Sirvent A, Dore E, Isfan F, Merlin E, Pereira B, Halle P, Rabiau N, Kanold J, Deméocq F.

Bone Marrow Transplant. 2013 Nov;48(11):1401-8. doi: 10.1038/bmt.2013.82. Epub 2013 Jun 10.

PMID:
23749103
16.

Curing acute lymphoblastic leukemia and avoiding osteonecrosis: can't we have it all?

Ducassou S, Pérel Y.

Pediatr Blood Cancer. 2013 May;60(5):713-4. doi: 10.1002/pbc.24388. Epub 2013 Jan 17. No abstract available.

PMID:
23335158
17.

Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).

Gorde-Grosjean S, Oberlin O, Leblanc T, Pacquement H, Donadieu J, Lambilliotte A, Schell M, Dommange F, Munzer M, Paillard C, Schmitt C, Lutz P, Edan C, Ansoborlo S, Stephan JL, Michel G, Thomas C, Perel Y, Robert A, Landman-Parker J.

Br J Haematol. 2012 Sep;158(5):649-56. doi: 10.1111/j.1365-2141.2012.09199.x. Epub 2012 Jul 4.

PMID:
22757721
18.

Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.

Gandemer V, Chevret S, Petit A, Vermylen C, Leblanc T, Michel G, Schmitt C, Lejars O, Schneider P, Demeocq F, Bader-Meunier B, Bernaudin F, Perel Y, Auclerc MF, Cayuela JM, Leverger G, Baruchel A; FRALLE Group.

Haematologica. 2012 Nov;97(11):1743-50. doi: 10.3324/haematol.2011.059584. Epub 2012 May 11.

19.

Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report.

Shankar A, Hall GW, Gorde-Grosjean S, Hasenclever D, Leblanc T, Hayward J, Lambilliotte A, Daw S, Perel Y, McCarthy K, Lejars O, Coulomb A, Oberlin WO, Wallace WH, Landman-Parker J.

Eur J Cancer. 2012 Jul;48(11):1700-6. doi: 10.1016/j.ejca.2011.10.018. Epub 2011 Nov 15.

PMID:
22093944
20.

Identification of a complex 17q rearrangement in a metanephric stromal tumor.

Toutain J, VuPhi Y, Doco-Fenzy M, Morice-Picard F, Stanislas S, Laharanne E, Cailley D, Vergnes P, Perel Y, Boccon-Gibod L, Deminiere C, Taine L.

Cancer Genet. 2011 Jun;204(6):340-3. doi: 10.1016/j.cancergen.2011.05.003.

PMID:
21763632
21.

A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.

Monnereau-Laborde S, Munzer C, Valteau-Couanet D, Ansoborlo S, Coze C, Chastagner P, Rubie H, Demeocq F, Stephan JL, Hartmann O, Perel Y.

Pediatr Blood Cancer. 2011 Dec 1;57(6):965-71. doi: 10.1002/pbc.23232. Epub 2011 Jul 8.

PMID:
21744481
22.

New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.

Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, Bader-Meunier B, Robert A, Nelken B, Gandemer V, Savel H, Stephan JL, Fouyssac F, Jeanpetit J, Thomas C, Rohrlich P, Baruchel A, Fischer A, Chêne G, Perel Y; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE).

Haematologica. 2011 May;96(5):655-63. doi: 10.3324/haematol.2010.036053. Epub 2011 Jan 12.

23.

Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.

Bourdeaut F, Lequin D, Brugières L, Reynaud S, Dufour C, Doz F, André N, Stephan JL, Pérel Y, Oberlin O, Orbach D, Bergeron C, Rialland X, Fréneaux P, Ranchere D, Figarella-Branger D, Audry G, Puget S, Evans DG, Pinas JC, Capra V, Mosseri V, Coupier I, Gauthier-Villars M, Pierron G, Delattre O.

Clin Cancer Res. 2011 Jan 1;17(1):31-8. doi: 10.1158/1078-0432.CCR-10-1795.

24.

Road traffic and childhood leukemia: the ESCALE study (SFCE).

Amigou A, Sermage-Faure C, Orsi L, Leverger G, Baruchel A, Bertrand Y, Nelken B, Robert A, Michel G, Margueritte G, Perel Y, Mechinaud F, Bordigoni P, Hémon D, Clavel J.

Environ Health Perspect. 2011 Apr;119(4):566-72. doi: 10.1289/ehp.1002429. Epub 2010 Dec 8.

25.

Myeloid leukaemia in children with Down syndrome: report of the registry-based French experience between 1990 and 2003.

Tandonnet J, Clavel J, Baruchel A, Nacka F, Pérel Y.

Pediatr Blood Cancer. 2010 Jul 1;54(7):927-33. doi: 10.1002/pbc.22515.

PMID:
20405513
26.

Ectopic Cushing's syndrome due to an adrenal ganglioneuroma.

Corcuff JB, Deminiere C, Trouillas J, Puel O, Perel Y, Barat P.

Horm Res Paediatr. 2010;73(5):405-8. doi: 10.1159/000308175. Epub 2010 Apr 14.

PMID:
20389113
27.

Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE).

Brosselin P, Rudant J, Orsi L, Leverger G, Baruchel A, Bertrand Y, Nelken B, Robert A, Michel G, Margueritte G, Perel Y, Mechinaud F, Bordigoni P, Hémon D, Clavel J.

Occup Environ Med. 2009 Sep;66(9):598-606. doi: 10.1136/oem.2008.042432. Epub 2009 Feb 12.

PMID:
19213757
28.

Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.

Gandemer V, Auclerc MF, Perel Y, Vannier JP, Le Gall E, Demeocq F, Schmitt C, Piguet C, Stephan JL, Lejars O, Debre M, Jonveaux P, Cayuela JM, Chevret S, Leverger G, Baruchel A; FRALLE group.

BMC Cancer. 2009 Jan 13;9:14. doi: 10.1186/1471-2407-9-14.

29.

Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.

Ballerini P, Landman-Parker J, Cayuela JM, Asnafi V, Labopin M, Gandemer V, Perel Y, Michel G, Leblanc T, Schmitt C, Fasola S, Hagemejier A, Sigaux F, Auclerc MF, Douay L, Leverger G, Baruchel A.

Haematologica. 2008 Nov;93(11):1658-65. doi: 10.3324/haematol.13291. Epub 2008 Oct 2.

30.

Surgical management of neuroblastoma-related hepatomegaly: do material and method really count?

Harper L, Perel Y, Lavrand F, Brissaud O.

Pediatr Hematol Oncol. 2008 Jun;25(4):313-7. doi: 10.1080/08880010802016086.

PMID:
18484475
31.

Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.

Oudot C, Auclerc MF, Levy V, Porcher R, Piguet C, Perel Y, Gandemer V, Debre M, Vermylen C, Pautard B, Berger C, Schmitt C, Leblanc T, Cayuela JM, Socie G, Michel G, Leverger G, Baruchel A.

J Clin Oncol. 2008 Mar 20;26(9):1496-503. doi: 10.1200/JCO.2007.12.2820.

PMID:
18349402
32.

Rituximab therapy for childhood Evans syndrome.

Bader-Meunier B, Aladjidi N, Bellmann F, Monpoux F, Nelken B, Robert A, Armari-Alla C, Picard C, Ledeist F, Munzer M, Yacouben K, Bertrand Y, Pariente A, Chaussé A, Perel Y, Leverger G.

Haematologica. 2007 Dec;92(12):1691-4.

33.

Familial history of cancer and childhood acute leukemia: a French population-based case-control study.

Ripert M, Menegaux F, Perel Y, Méchinaud F, Plouvier E, Gandemer V, Lutz P, Vannier JP, Lamagnére JP, Margueritte G, Boutard P, Robert A, Armari-Alla C, Munzer M, Millot F, de Lumley L, Berthou C, Rialland X, Pautard B, Clavel J.

Eur J Cancer Prev. 2007 Oct;16(5):466-70.

34.

Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE).

Mallol-Mesnard N, Menegaux F, Auvrignon A, Auclerc MF, Bertrand Y, Nelken B, Robert A, Michel G, Margueritte G, Perel Y, Méchinaud F, Bordigoni P, Leverger G, Baruchel A, Hémon D, Clavel J.

Int J Epidemiol. 2007 Feb;36(1):110-6. Epub 2007 Jan 16.

35.

Psoriasis after cord blood stem cell transplantation.

Hubiche T, Leaute-Labreze C, Lepreux S, Perel Y, Taïeb A.

Br J Dermatol. 2007 Feb;156(2):386-8. No abstract available.

PMID:
17223889
36.

Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children.

Dufourg MN, Landman-Parker J, Auclerc MF, Schmitt C, Perel Y, Michel G, Levy P, Couillault G, Gandemer V, Tabone MD, Demeocq F, Vannier JP, Leblanc T, Leverger G, Baruchel A.

Leukemia. 2007 Feb;21(2):238-47. Epub 2006 Dec 14.

PMID:
17170721
37.

[Management of acute phase of autoimmune haemolytic anemia].

Pérel Y, Aladjidi N, Jeanne M.

Arch Pediatr. 2006 Jun;13(6):514-7. Epub 2006 May 11. French. No abstract available.

PMID:
16690298
38.

[Epidemiology of autoimmune haemolytic anemia in children: French data].

Aladjidi N, Leverger G, Pariente A, Bader-Meunier B, Le Deist F, Colin Y, Michel G, Quartier P, Pondaré C, Monpoux F, Leblanc T, Nelken B, Lutz P, Blouin P, Yacouben K, Robert A, Stephan JL, Perel Y.

Arch Pediatr. 2006 Jun;13(6):511-4. Epub 2006 May 11. French. No abstract available.

PMID:
16690271
39.

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.

Bernard F, Thomas C, Bertrand Y, Munzer M, Landman Parker J, Ouache M, Colin VM, Perel Y, Chastagner P, Vermylen C, Donadieu J.

Eur J Cancer. 2005 Nov;41(17):2682-9. Epub 2005 Apr 7.

PMID:
16291085
40.

[Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)].

Blouin P, Auvrignon A, Pagnier A, Thuret I, Antoni G, Bader-Meunier B, Le Deist F, Chastagner P, Aladjidi N, Pellier I, Bertrand Y, Behar C, Landmann-Parker J, Leverger G, Perel Y.

Arch Pediatr. 2005 Nov;12(11):1600-7. Epub 2005 Sep 26. French.

PMID:
16185853
41.

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.

Perel Y, Auvrignon A, Leblanc T, Michel G, Reguerre Y, Vannier JP, Dalle JH, Gandemer V, Schmitt C, Méchinaud F, Lejars O, Piguet C, Couillaud G, Pautard B, Landman-Parker J, Thuret I, Aladjidi N, Baruchel A, Leverger G; French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.

Leukemia. 2005 Dec;19(12):2082-9.

PMID:
16121218
42.

Expression patterns of nm23 genes during mouse organogenesis.

Amrein L, Barraud P, Daniel JY, Pérel Y, Landry M.

Cell Tissue Res. 2005 Dec;322(3):365-78. Epub 2005 Aug 5.

PMID:
16082520
43.

Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.

Berger C, Le-Gallo B, Donadieu J, Richard O, Devergie A, Galambrun C, Bordigoni P, Vilmer E, Plouvier E, Perel Y, Michel G, Stephan JL.

Bone Marrow Transplant. 2005 May;35(10):991-5.

PMID:
15806126
44.

Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.

Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O.

J Clin Oncol. 2005 Jan 20;23(3):532-40.

PMID:
15659499
45.

High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.

Laprie A, Michon J, Hartmann O, Munzer C, Leclair MD, Coze C, Valteau-Couanet D, Plantaz D, Carrie C, Habrand JL, Bergeron C, Chastagner P, Défachelles AS, Delattre O, Combaret V, Bénard J, Pérel Y, Gandemer V, Rubie H; Neuroblastoma Study Group of the French Society of Pediatric Oncology.

Cancer. 2004 Sep 1;101(5):1081-9.

46.

Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register.

Cassinat B, Bellanné-Chantelot C, Notz-Carrère A, Menot ML, Vaury C, Micheau M, Bader-Meunier B, Perel Y, Leblanc T, Donadieu J, Chomienne C.

Leukemia. 2004 Sep;18(9):1553-5. No abstract available.

PMID:
15284863
47.

[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].

Pérel Y, Valteau-Couanet D, Michon J, Lavrand F, Coze C, Bergeron C, Notz A, Plantaz D, Chastagner P, Bernard F, Thomas C, Rubie H.

Arch Pediatr. 2004 Jul;11(7):834-42. Review. French.

PMID:
15234382
48.

[Neonatal localized neuroblastoma: 52 cases treated from 1990 to 1999].

Michalowski MB, Rubie H, Michon J, Montamat S, Bergeron C, Coze C, Perel Y, Valteau-Couanet D, Guitard J, Guys JM, Piolat C, Munzer C, Plantaz D; Groupe Neuroblastome de la Société Française d'Oncologie Pédiatrique.

Arch Pediatr. 2004 Jul;11(7):782-8. French.

PMID:
15234372
49.

Maintenance therapy in childhood acute myeloid leukemia.

Perel Y, Auvrignon A, Leblanc T, Michel G, Vannier JP, Dalle JH, Gandemer V, Schmitt C, Mèchinaud F, Lamagnere JP, Piguet Ch, Couillaud G, Pautard B, Baruchel A, Leverger G; Group LAME; French Society of Pediatric Hematology and Immunology.

Ann Hematol. 2004;83 Suppl 1:S116-9.

PMID:
15124700
50.

Differential expression of the nm23 genes in the developing human trophoblast.

Guyon F, Marnet B, Arnaud-Dabernat S, Carles D, Mathieu C, Saura R, Perel Y, Horovitz J, Landry M, Bischof P, Daniel JY.

Placenta. 2004 Jan;25(1):20-8.

PMID:
15013635

Supplemental Content

Support Center